Related Experiment Video

Updated: Aug 23, 2026

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
04:27

Intratracheal Instillation of Stem Cells in Term Neonatal Rats

Published on: May 4, 2020

Vitamin A and bronchopulmonary dysplasia: research, issues, and clinical practice

Anne M Mentro1

  • 1The Ohio State University College of Nursing, Atlanta, GA 30350, USA. mentro.1@osu.edu

Neonatal Network : NN
|August 20, 2004
PubMed

Insights

Vitamin A supplementation is vital for preterm infants to protect lungs from oxygen damage. However, current research shows only modest improvements in bronchopulmonary dysplasia (BPD) and clinical outcomes despite increased vitamin A levels.

Area of Science:

  • Neonatal Medicine
  • Nutritional Science
  • Pediatric Pulmonology

Background:

  • Vitamin A is a critical antioxidant, protecting preterm infants' lungs from oxidative stress caused by supplemental oxygen.
  • Preterm infants, especially those at risk for bronchopulmonary dysplasia (BPD), often have particularly deficient vitamin A stores at birth.
  • Oxidative damage is a significant concern in the neonatal intensive care unit.

Purpose of the Study:

  • To review the current research on vitamin A supplementation in preterm infants.
  • To discuss the challenges and clinical implications of vitamin A interventions for this vulnerable population.
  • To evaluate the effectiveness of vitamin A in preventing BPD.

Main Methods:

  • Review of existing scientific literature and clinical trials on vitamin A supplementation in preterm neonates.
  • Analysis of studies examining plasma vitamin A concentrations and their correlation with clinical outcomes.
  • Examination of research focusing on the incidence of bronchopulmonary dysplasia (BPD) in supplemented versus unsupplemented infants.

Main Results:

  • Vitamin A supplementation has successfully increased plasma vitamin A concentrations in preterm infants.
  • Despite increased vitamin A levels, clinical outcomes and the incidence of BPD have shown only modest improvements.
  • The specific benefits and optimal dosing strategies require further investigation.

Conclusions:

  • Vitamin A remains an important consideration for preterm infant nutrition due to its antioxidant properties.
  • Current supplementation protocols yield limited clinical benefits regarding BPD and overall outcomes.
  • Further research is needed to optimize vitamin A therapy and address the complexities of its use in preterm neonates.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...